Terbutaline sulfate inj
Products billed under this code include Terbutaline Sulfate.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Terbutaline Sulfate.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Terbutaline Sulfate | Hikma Pharmaceuticals USA Inc. | 00143-9375-10 | 10 | $10.00 |
| Terbutaline Sulfate | Hikma Pharmaceuticals USA Inc. | 00143-9746-10 | 10 | $10.00 |
| Terbutaline Sulfate | Henry Schein Inc. | 00404-9962-01 | 1 | $1.00 |
| Terbutaline Sulfate | Areva Pharmaceuticals | 59923-0615-05 | 5 | $5.00 |
| Terbutaline Sulfate | FreseniUS Kabi USA, LLC | 63323-0665-01 | 25 | $25.00 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $1.00 | −$1.82 | 1 MG | Terbutaline sulfate inj | v1, posted September 17, 2026 |
| 3Q26 | $2.82 | −$0.143 | 1 MG | Terbutaline sulfate inj | v1, posted September 15, 2026 |
| 2Q26 | $2.963 | +$0.49 | 1 MG | Terbutaline sulfate inj | v1, posted September 15, 2026 |
| 1Q26 | $2.473 | −$4.918 | 1 MG | Terbutaline sulfate inj | v1, posted September 15, 2026 |
| 4Q25 | $7.391 | +$4.649 | 1 MG | Terbutaline sulfate inj | v1, posted September 8, 2026 |
| 3Q25 | $2.742 | +$1.329 | 1 MG | Terbutaline sulfate inj | v1, posted March 10, 2026 |
| 2Q25 | $1.413 | −$0.73 | 1 MG | Terbutaline sulfate inj | v1, posted March 10, 2026 |
| 1Q25 | $2.143 | −$0.124 | 1 MG | Terbutaline sulfate inj | v1, posted December 19, 2025 |
| 4Q24 | $2.267 | −$1.396 | 1 MG | Terbutaline sulfate inj | v1, posted June 11, 2025 |
| 3Q24 | $3.663 | −$2.424 | 1 MG | Terbutaline sulfate inj | v1, posted June 11, 2025 |
| 2Q24 | $6.087 | −$1.707 | 1 MG | Terbutaline sulfate inj | v1, posted March 11, 2025 |
| 1Q24 | $7.794 | −$6.51 | 1 MG | Terbutaline sulfate inj | v1, posted December 19, 2024 |
| 4Q23 | $14.304 | +$12.014 | 1 MG | Terbutaline sulfate inj | v1, posted October 10, 2024 |
| 3Q23 | $2.29 | +$1.451 | 1 MG | Terbutaline sulfate inj | v1, posted June 5, 2024 |
| 2Q23 | $0.839 | −$0.482 | 1 MG | Terbutaline sulfate inj | v1, posted February 23, 2024 |
| 1Q23 | $1.321 | −$11.449 | 1 MG | Terbutaline sulfate inj | v1, posted December 6, 2023 |
| 4Q22 | $12.77 | +$9.573 | 1 MG | Terbutaline sulfate inj | v1, posted June 22, 2023 |
| 3Q22 | $3.197 | +$0.224 | 1 MG | Terbutaline sulfate inj | v1, posted June 9, 2023 |
| 2Q22 | $2.973 | +$1.171 | 1 MG | Terbutaline sulfate inj | v1, posted December 14, 2022 |
| 1Q22 | $1.802 | −$0.729 | 1 MG | Terbutaline sulfate inj | v1, posted June 8, 2022 |
| 4Q21 | $2.531 | +$1.159 | 1 MG | Terbutaline sulfate inj | v1, posted June 2, 2022 |
| 3Q21 | $1.372 | −$0.61 | 1 MG | Terbutaline sulfate inj | v1, posted June 2, 2022 |
| 2Q21 | $1.982 | −$3.172 | 1 MG | Terbutaline sulfate inj | v1, posted March 1, 2022 |
| 1Q21 | $5.154 | – | 1 MG | Terbutaline sulfate inj | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.